MS436
CAS: 1395084-25-9
Ref. 3D-VFC08425
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
- Ms436
- (E)-4-[2-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-N-2-pyridinylbenzenesulfonamide
- MS 436
MS436 is a chemical compound that is currently in clinical trials for the treatment of cancer. It has been shown to inhibit the activity of CDK4/6, which are proteins that regulate cell cycle progression and play a role in cardiac physiology. MS436 also inhibits the HDAC enzyme, which plays a key role in regulating gene expression and cellular physiology. This drug has been shown to have anticancer activity in xenograft tumor growth studies. In addition, it has been shown to inhibit the bromodomain-containing protein BRD4, which is implicated in cancer development.
Chemical properties
Technical inquiry about: 3D-VFC08425 MS436
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
